Ann Rheum Dis -- Table of Contents (64 [Supplement 4 ])

Subscribe here
Activate your subscription

Home > Volume 64, Suppl 4

Receive tables of contents (and more) by e-mail each issue: Subscribe to Customised @lerts

November 2005 (Volume 64, Supplement 4 ). [Index by author]

Advances in targeted therapies VII

Find articles in this issue containing these words: [Search ALL Issues]

Table of Contents (PDF)

	Advances in targeted therapies VII F C Breedveld, J R Kalden, and J S Smolen Ann Rheum Dis 2005; 64 (Supplement 4 ): iv1. doi:10.1136/ard.2005.044339 [Extract] [Full text] [PDF] [Request Permissions]

	Updated consensus statement on biological agents, specifically tumour necrosis factor ${alpha}$ (TNF ${alpha}$ ) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005 D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, J W J Bijlsma, M Dougados, P Emery, E C Keystone, L Klareskog, and P J Mease Ann Rheum Dis 2005; 64 (Supplement 4 ): iv2-iv14. doi:10.1136/ard.2005.044941 [Extract] [Full text] [Erratum] [PDF] [Request Permissions]

	Stimulation of autoimmunity by toll-like receptor ligands A Limmer, R Ganss, N Garbi, B Arnold, and G J Hämmerling Ann Rheum Dis 2005; 64 (Supplement 4 ): iv15-iv17. doi:10.1136/ard.2005.042556 [Extract] [Full text] [PDF] [Request Permissions]

	Biological drug use: US perspectives on indications and monitoring J J Cush Ann Rheum Dis 2005; 64 (Supplement 4 ): iv18-iv23. doi:10.1136/ard.2005.042549 [Abstract] [Full text] [PDF] [Request Permissions]

	Immunological control of tuberculosis: role of tumour necrosis factor and more S Stenger Ann Rheum Dis 2005; 64 (Supplement 4 ): iv24-iv28. doi:10.1136/ard.2005.042531 [Abstract] [Full text] [PDF] [Request Permissions]

	Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor ${alpha}$ K L Winthrop Ann Rheum Dis 2005; 64 (Supplement 4 ): iv29-iv30. doi:10.1136/ard.2005.042390 [Extract] [Full text] [PDF] [Request Permissions]

	Current state of tumour necrosis factor ${alpha}$ blockade in Wegener’s granulomatosis C Mukhtyar and R Luqmani Ann Rheum Dis 2005; 64 (Supplement 4 ): iv31-iv36. doi:10.1136/ard.2005.042416 [Abstract] [Full text] [PDF] [Request Permissions]

	The CORRONA database J Kremer Ann Rheum Dis 2005; 64 (Supplement 4 ): iv37-iv41. doi:10.1136/ard.2005.043497 [Extract] [Full text] [PDF] [Request Permissions]

	The British Society for Rheumatology Biologics Register K Watson, D Symmons, I Griffiths, and A Silman Ann Rheum Dis 2005; 64 (Supplement 4 ): iv42-iv43. doi:10.1136/ard.2005.042499 [Abstract] [Full text] [PDF] [Request Permissions]

	What are the roles of metalloproteinases in cartilage and bone damage? G Murphy and M H Lee Ann Rheum Dis 2005; 64 (Supplement 4 ): iv44-iv47. doi:10.1136/ard.2005.042465 [Abstract] [Full text] [PDF] [Request Permissions]

	Presentation and analysis of radiographic data in clinical trials and observational studies R Landewé and D van der Heijde Ann Rheum Dis 2005; 64 (Supplement 4 ): iv48-iv51. doi:10.1136/ard.2005.042572 [Abstract] [Full text] [PDF] [Request Permissions]

	Are fibroblasts involved in joint destruction? T Pap, I Meinecke, U Müller-Ladner, and S Gay Ann Rheum Dis 2005; 64 (Supplement 4 ): iv52-iv54. doi:10.1136/ard.2005.042424 [Extract] [Full text] [PDF] [Request Permissions]

	Update on rituximab R Eisenberg Ann Rheum Dis 2005; 64 (Supplement 4 ): iv55-iv57. doi:10.1136/ard.2005.042648 [Extract] [Full text] [PDF] [Request Permissions]

	Alefacept for psoriasis and psoriatic arthritis A B Gottlieb Ann Rheum Dis 2005; 64 (Supplement 4 ): iv58-iv60. doi:10.1136/ard.2005.042655 [Abstract] [Full text] [PDF] [Request Permissions]

	How early should ankylosing spondylitis be treated with tumour necrosis factor blockers? J Sieper and M Rudwaleit Ann Rheum Dis 2005; 64 (Supplement 4 ): iv61-iv64. doi:10.1136/ard.2005.042432 [Abstract] [Full text] [PDF] [Request Permissions]

	Health economics: implications for novel antirheumatic therapies A Kavanaugh Ann Rheum Dis 2005; 64 (Supplement 4 ): iv65-iv69. doi:10.1136/ard.2005.042440 [Abstract] [Full text] [PDF] [Request Permissions]

	What does tumour necrosis factor excess do to the immune system long term? J Clark, P Vagenas, M Panesar, and A P Cope Ann Rheum Dis 2005; 64 (Supplement 4 ): iv70-iv76. doi:10.1136/ard.2005.042523 [Abstract] [Full text] [PDF] [Request Permissions]

	How does B cell depletion therapy work, and how can it be improved? E A Clark and J A Ledbetter Ann Rheum Dis 2005; 64 (Supplement 4 ): iv77-iv80. doi:10.1136/ard.2005.042507 [Abstract] [Full text] [PDF] [Request Permissions]

	IKKß as a target for treatment of inflammation induced bone loss M G Ruocco and M Karin Ann Rheum Dis 2005; 64 (Supplement 4 ): iv81-iv85. doi:10.1136/ard.2005.042721 [Abstract] [Full text] [PDF] [Request Permissions]

	Dendritic cells: potential triggers of autoimmunity and targets for therapy J A Hardin Ann Rheum Dis 2005; 64 (Supplement 4 ): iv86-iv90. doi:10.1136/ard.2005.044560 [Extract] [Full text] [PDF] [Request Permissions]

	Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases N Beyersdorf, T Hanke, T Kerkau, and T Hünig Ann Rheum Dis 2005; 64 (Supplement 4 ): iv91-iv95. doi:10.1136/ard.2005.042564 [Abstract] [Full text] [PDF] [Request Permissions]

	The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders J M Ilarregui, G A Bianco, M A Toscano, and G A Rabinovich Ann Rheum Dis 2005; 64 (Supplement 4 ): iv96-iv103. doi:10.1136/ard.2005.044347 [Abstract] [Full text] [PDF] [Request Permissions]

	Toll-like receptor 2 signalling and inflammation F Y Liew, M Patel, and D Xu Ann Rheum Dis 2005; 64 (Supplement 4 ): iv104-iv105. doi:10.1136/ard.2005.042515 [Extract] [Full text] [PDF] [Request Permissions]

	The 2005 International Symposium on Advances in Targeted Therapies: What have we learned in the 2000s and where are we going? R N Maini Ann Rheum Dis 2005; 64 (Supplement 4 ): iv106-iv108. doi:10.1136/ard.2005.042408 [Abstract] [Full text] [PDF] [Request Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstracts' button. To see one abstract at a time, click its [Abstract] link.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs

Show me all >>